ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Attitudes Towards Prophylactic Colectomy in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients

This study is currently recruiting participants.
Verified by Memorial Sloan-Kettering Cancer Center, June 2008

Sponsors and Collaborators: Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Information provided by: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00582452
  Purpose

The purpose of this study is to learn more about individual's with a family history of colon cancer and the process by which they may decide to undergo or not undergo prophylactic colectomy. This is a surgery to remove the colon in order to reduce risk of cancer (or of getting cancer again).


Condition Intervention
Colorectal Cancer
Other: Telephone survey

Genetics Home Reference related topics:   Lynch syndrome   

MedlinePlus related topics:   Cancer    Colorectal Cancer   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Family-Based, Cross-Sectional
Official Title:   Attitudes Towards Prophylactic Colectomy in HNPCC Patients

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • To assess levels of intention in prophylactic colectomy among individuals at increased familial risk of colorectal cancer and to identify distinctive decision types based on profiles of perceived pros and cons of prophylactic colectomy; [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   330
Study Start Date:   November 2004
Estimated Study Completion Date:   November 2009
Estimated Primary Completion Date:   November 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts Assigned Interventions
2
Affected patients who are at high risk for metachronous colorectal tumors due to mutation status.
Other: Telephone survey
Telephone survey
1
Unaffected patients who are at high risk for developing colon cancer based on family history and/or mutation status.
Other: Telephone survey
Telephone survey

Detailed Description:

Hereditary non-polyposis colorectal cancer (HNPCC) is associated with up to an 80% lifetime risk of developing colorectal cancer and a 40-50% chance of a metachronous tumor after partial colectomy for the disease. For these patients, prophylactic colectomy has been proposed as a potential risk management alternative to a lifetime of intensive surveillance by colonoscopy. The highly personal nature of such risk management decisions has been recognized in the development of individualized genetic counseling services. However, prior psychosocial research in this area has tended to use linear statistical techniques in which clinically important details are lost in an overly broad, onesize-fits-all model that is difficult to apply in a one-to-one counseling session. We propose an innovative approach based on the Cognitive-Social Health Information Processing (C-SHIP) model in which we will explore how attitudes towards prophylactic colectomy are organized into meaningful patterns or types that can translate readily into tailored counseling recommendations. Specific aims of this study are: 1)to assess levels of intention in prophylactic colectomy among HNPCC patients; 2)To identify distinctive decision types based on profiles of perceived pros and cons of prophylactic colectomy; and 3) To explore the pattern of relations between decision types and counseling-related outcomes (level of intention in colectomy, cancer-specific anxiety, and colonoscopy adherence). We will conduct a one-time cross-sectional telephone survey of 320 HNPCC patients (defined as either carriers of a mutated mismatch repair gene associated with HNPCC or those with a personal/family history meeting published criteria for HNPCC). Using cluster analysis we will create a taxonomy of decision types. Prior research leads us to expect at least three types: Disengaged, Risk-Focused, and Ambivalent. We hypothesize that each type will have a different pattern of relations with the outcome variables (e.g., Risk-focused types will show higher level of intention regarding surgery, high anxiety, low avoidance, and high colonoscopy adherence, whereas Ambivalent types will show higher level of intention regarding surgery, high anxiety, high avoidance, and low colonoscopy adherence). Understanding these patterns will enhance the ability of physicians, genetic counselors, and other providers to help their patients make wellinformed, thoughtful decisions about the preventive strategy that will best protect their health, emotional well-being, and quality of life.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

Unaffected patients who are at high risk for developing colon cancer based on family history and/or mutation status, and affected patients who are at high risk for metachronous colorectal tumors due to mutation status.


Criteria

Inclusion Criteria:

  • are from a family that has a known mismatch repair mutation; or
  • meet Amsterdam I or Amsterdam II criteria that spell out the family and personal cancer history characteristics associated with HNPCC
  • are considered at sufficiently high risk by their CRC specialty physician that prophylactic colectomy may be presented as an option (excluding FAP).

Exclusion Criteria:

  • non-English speaking
  • under the age of 18
  • are unable to give meaningful informed consent due to physical, psychiatric or cognitive disability
  • are from a family affected by FAP
  • have already undergone subtotal colectomy or total proctocolectomy
  • are in active treatment and/or less than six months post-surgery for cancer.
  • Have undergone genetic counseling and testing for HNPCC at MSKCC
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00582452

Contacts
Contact: Karen Hurley, PhD     hurleyk@mskcc.org    

Locations
United States, New York
Memorial Sloan Kettering Cancer Center     Recruiting
      New York, New York, United States, 10065
      Contact: Karen Hurley, PhD         hurleyk@mskcc.org    
      Principal Investigator: Karen Hurley, PhD            

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)

Investigators
Principal Investigator:     Karen Hurley, PhD     Memorial Sloan-Kettering Cancer Center    
  More Information


Related Info  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Memorial Sloan Kettering Cancer Center ( Karen Hurley, PhD )
Study ID Numbers:   04-127, NCI CA101511, CA109236
First Received:   December 21, 2007
Last Updated:   June 18, 2008
ClinicalTrials.gov Identifier:   NCT00582452
Health Authority:   United States: Food and Drug Administration

Keywords provided by Memorial Sloan-Kettering Cancer Center:
HNPCC  
prophylactic colectomy  

Study placed in the following topic categories:
Digestive System Neoplasms
Metabolic Diseases
Gastrointestinal Diseases
Colonic Diseases
Hereditary nonpolyposis colon cancer
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Digestive System Diseases
Neoplastic Syndromes, Hereditary
Colorectal Neoplasms, Hereditary Nonpolyposis
Genetic Diseases, Inborn
Colorectal cancer, hereditary nonpolyposis, type 1
Gastrointestinal Neoplasms
Metabolic disorder
Colorectal Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site
DNA Repair-Deficiency Disorders

ClinicalTrials.gov processed this record on October 31, 2008




Links to all studies - primarily for crawlers